Hereditary cancer testing policy reminder

Immediately: Billing team must update claim submission guidelines to flag and deny multigene RNA panel hereditary cancer tests across all affected UnitedHealthcare plans. Implement system logic to differentiate between covered DNA-only panels and non-covered multigene RNA panels. Update provider encounter forms and templates to indicate that multigene RNA hereditary cancer panels require denial with reason code 'unproven service.' Train billing staff and providers that hereditary cancer panels performed simultaneously with multigene RNA analysis will be denied. Failure to apply this policy will result in claims being processed for non-covered services, requiring subsequent denial and potential recovery efforts.